These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 35435190)

  • 21. Acute viral hepatitis presenting as cytomegalovirus, hepatitis E and Epstein-Barr virus IgM antibody positive.
    Huang Q; Li XH; Zhu C; Yan J; Song Z; Zhang S; Hu Y; Chen L; Ling Y
    Antivir Ther; 2016; 21(2):171-3. PubMed ID: 26376744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytomegalovirus infection: its incidence and management in cytomegalovirus-seropositive living related liver transplant recipients: a single-center experience.
    Wadhawan M; Gupta S; Goyal N; Vasudevan KR; Makki K; Dawar R; Sardana R; Lal N; Kumar A
    Liver Transpl; 2012 Dec; 18(12):1448-55. PubMed ID: 22903934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A cross-sectional study on maternal anxiety levels after cytomegalovirus screening.
    Uehara K; Kaneko M; Matsuoka A; Kuroki M; Minematsu T
    J Psychosom Obstet Gynaecol; 2020 Sep; 41(3):240-245. PubMed ID: 31466495
    [No Abstract]   [Full Text] [Related]  

  • 24. Detection of IgM antibody to cytomegalovirus and rapid diagnosis of this virus infection by the shell vial assay.
    Smith TF; Shelley CD
    J Virol Methods; 1988 Sep; 21(1-4):87-96. PubMed ID: 2846623
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential impact of different cytomegalovirus (CMV) IgM assays on an algorithm requiring IgM reactivity as a criterion for measuring CMV IgG avidity.
    Prince HE; Lapé-Nixon M; Brenner A; Pitstick N; Couturier MR
    Clin Vaccine Immunol; 2014 Jun; 21(6):813-6. PubMed ID: 24671558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effectiveness of preemptive therapy with ganciclovir in recipients of renal transplants at high risk (R-/D+) for the development of cytomegalovirus disease].
    Aranda-Verástegui F; Alberú J; Soto-Ramírez LE; González-Aguirre H; Muñoz Trejo T; Mancilla E; Díliz H; Correa-Rotter R; Sierra-Madero J
    Rev Invest Clin; 2002; 54(3):198-203. PubMed ID: 12183888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect and safety of granulocyte-monocyte adsorption apheresis for patients with ulcerative colitis positive for cytomegalovirus in comparison with immunosuppressants.
    Yoshino T; Nakase H; Matsuura M; Matsumura K; Honzawa Y; Fukuchi T; Watanabe K; Murano M; Tsujikawa T; Fukunaga K; Matsumoto T; Chiba T
    Digestion; 2011; 84(1):3-9. PubMed ID: 21311190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prenatal diagnosis of congenital cytomegalovirus infection in 189 pregnancies with known outcome.
    Enders G; Bäder U; Lindemann L; Schalasta G; Daiminger A
    Prenat Diagn; 2001 May; 21(5):362-77. PubMed ID: 11360277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Positive predictive values of CMV-IgM and importance of CMV-IgG avidity testing in detecting primary infection in three different clinical settings. A French retrospective cohort study.
    Périllaud-Dubois C; Bouthry E; Jadoui A; Leng AL; Roque-Afonso AM; Vauloup-Fellous C
    J Clin Virol; 2020 Nov; 132():104641. PubMed ID: 32947202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Indirect immunofluorescence test for detection of IgM antibodies to cytomegalovirus.
    Hekker AC; Brand-Saathof B; Vis J; Meijers RC
    J Infect Dis; 1979 Oct; 140(4):596-600. PubMed ID: 229176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CMV antigenemia (the lower matrix protein PP65), a marker for the guidance of antiviral therapy in cytomegalovirus disease after orthotopic heart transplantation.
    Iberer F; Tscheliessnigg KH; Halwachs G; Auer T; Wasler A; Petutschnigg B; Müller H; Freigassner M; Allmayr T; Hipmair G
    Wien Klin Wochenschr; 1995; 107(23):718-22. PubMed ID: 8560893
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of serology assays and polymerase chain reaction for the monitoring of active cytomegalovirus infection in renal transplant recipients.
    Naumnik B; Małyszko J; Chyczewski L; Kovalchuk O; Małyszko J; Myśliwiec M
    Transplant Proc; 2007 Nov; 39(9):2748-50. PubMed ID: 18021976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a new cytomegalovirus (CMV) immunoglobulin M (IgM) immunoblot for detection of CMV-specific IgM.
    Lazzarotto T; Ripalti A; Bergamini G; Battista MC; Spezzacatena P; Campanini F; Pradelli P; Varani S; Gabrielli L; Maine GT; Landini MP
    J Clin Microbiol; 1998 Nov; 36(11):3337-41. PubMed ID: 9774589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of IgG avidity in diagnosis of cytomegalovirus infection in newborns and infants.
    Vilibić-Cavlek T; Ljubin-Sternak S; Vojnović G; Sviben M; Mlinarić-Galinović G
    Coll Antropol; 2012 Mar; 36(1):297-300. PubMed ID: 22816235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Qualitative plasma PCR assay (AMPLICOR CMV test) versus pp65 antigenemia assay for monitoring cytomegalovirus viremia and guiding preemptive ganciclovir therapy in allogeneic stem cell transplantation.
    Solano C; Muñoz I; Gutiérrez A; Farga A; Prósper F; García-Conde J; Navarro D; Gimeno C
    J Clin Microbiol; 2001 Nov; 39(11):3938-41. PubMed ID: 11682510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elimination of nonspecific cytomegalovirus immunoglobulin M activities in the enzyme-linked immunosorbent assay by using anti-human immunoglobulin G.
    Joassin L; Reginster M
    J Clin Microbiol; 1986 Mar; 23(3):576-81. PubMed ID: 3007570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of CMV pp65 antigen and IgM antibody detection for early recognition of CMV primary infection and reactivation.
    Jahan M; Tabassum S; Islam M
    Mymensingh Med J; 2008 Jan; 17(1):28-31. PubMed ID: 18285727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low IgG avidity and ultrasound fetal abnormality predict congenital cytomegalovirus infection.
    Sonoyama A; Ebina Y; Morioka I; Tanimura K; Morizane M; Tairaku S; Minematsu T; Inoue N; Yamada H
    J Med Virol; 2012 Dec; 84(12):1928-33. PubMed ID: 23080498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of an in-house assay for cytomegalovirus immunoglobulin G (CMV IgG) avidity and relationship of avidity to CMV IgM levels.
    Prince HE; Leber AL
    Clin Diagn Lab Immunol; 2002 Jul; 9(4):824-7. PubMed ID: 12093680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Comparative Study Between Cytomegalovirus Immunoglobulin M-Positive and CMV Immunoglobulin M-Negative Biliary Atresia in Infants Attending a Tertiary Care Hospital in Bangladesh.
    Akter S; Karim ASMB; Mazumder MW; Rukunuzzaman M; Nahid KL; Dey BP; Sayeed M; Rahman AZMR; Fathema K; Khadga M
    Pediatr Gastroenterol Hepatol Nutr; 2022 Sep; 25(5):413-421. PubMed ID: 36148290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.